Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia ; volume:9 ; number:1 ; day:14 ; month:2 ; year:2019 ; pages:1-6 ; date:12.2019
Scientific reports ; 9, Heft 1 (14.2.2019), 1-6, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Namdaroglu, Sinem
Kaya, Ali Hakan
Batgi, Hikmettullah
Kayikci, Omur
Dal, Mehmet Sinan
Iskender, Dicle
Kizil Cakar, Merih
Tekgunduz, Emre
Altuntas, Fevzi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-38644-1
- URN
-
urn:nbn:de:101:1-2019031015520139969152
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Namdaroglu, Sinem
- Kaya, Ali Hakan
- Batgi, Hikmettullah
- Kayikci, Omur
- Dal, Mehmet Sinan
- Iskender, Dicle
- Kizil Cakar, Merih
- Tekgunduz, Emre
- Altuntas, Fevzi
- SpringerLink (Online service)
Other Objects (12)
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation